MET

MetLife Declares Preferred Stock Dividends

Metlife, Inc. (NYSE: MET) has declared its preferred stock dividends for the third quarter of 2024. The company announced the following dividends:

  • Quarterly dividend of $0.41713578 per share on the company’s floating rate non-cumulative preferred stock, Series A
  • Semi-annual dividend of $29.375 per share on the company’s 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D
  • Quarterly dividend of $351.5625 per share on the company’s 5.625% non-cumulative preferred stock, Series E
  • Quarterly dividend of $296.875 per share on the company’s 4.75% non-cumulative preferred stock, Series F
  • Semi-annual dividend of $19.250 per share on the company’s 3.850% fixed rate reset non-cumulative preferred stock, Series G

These dividends will be payable on September 16, 2024, to shareholders of record as of Friday, August 30, 2024.

Compared to the previous period, the dividends for the preferred stocks have either remained the same or changed. For example, the dividend for the floating rate non-cumulative preferred stock, Series A, has remained unchanged. On the other hand, the dividend for the 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, has changed since the last period. Similarly, the dividends for the non-cumulative preferred stocks Series E, F, and G have also either remained the same or changed compared to the previous period. Following these announcements, the company's shares moved 1.4%, and are now trading at a price of $72.72. For the full picture, make sure to review MetLife's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS